Literature DB >> 36098933

Streptococcus mutans glutamate binding protein (GlnH) as antigen target for a mucosal anti-caries vaccine.

Gisela de Souza Pereira1, Milene Tavares Batista1, Nayara Fernanda Barros Dos Santos1, Hélic Moreira Passos1, Dalva Adelina da Silva1, Ewerton Lucena Ferreira1, Luís Carlos de Souza Ferreira1, Rita de Cássia Café Ferreira2.   

Abstract

BACKGROUND: In recent years, several studies have demonstrated that bacterial ABC transporters present relevant antigen targets for the development of vaccines against bacteria such as Streptococcus pneumoniae and Enterococcus faecalis. In Streptococcus mutans, the glutamate transporter operon (glnH), encoding an ABC transporter, is associated with acid tolerance and represents an important virulence-associated factor for the development of dental caries.
RESULTS: In this study, we generated a recombinant form of the S. mutans GlnH protein (rGlnH) in Bacillus subtilis. Mice immunized with this protein antigen elicited strong antigen-specific antibody responses after sublingual administration of a vaccine formulation containing a mucosal adjuvant, a non-toxic derivative of the heat-labile toxin (LTK63) originally produced by enterotoxigenic Escherichia coli (ETEC) strains. Serum anti-rGlnH antibodies reduced adhesion of S. mutans to the oral cavity of naïve mice. Moreover, mice actively immunized with rGlnH were partially protected from oral colonization after exposure to the S. mutans NG8 strain.
CONCLUSIONS: Our results indicate that S. mutans rGlnH is a potential target antigen capable of inducing specific and protective antibody responses after immunization. Overall, these observations raise the prospect of the development of mucosal anti-caries vaccines.
© 2022. The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia.

Entities:  

Keywords:  ABC transporters; Anti-caries vaccines; Dental caries; GlnH; LTK63; Mucosal adjuvant; Streptococcus mutans

Year:  2022        PMID: 36098933     DOI: 10.1007/s42770-022-00823-0

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.214


  27 in total

Review 1.  ABC transporters: physiology, structure and mechanism--an overview.

Authors:  C F Higgins
Journal:  Res Microbiol       Date:  2001 Apr-May       Impact factor: 3.992

Review 2.  ABC transporters: from microorganisms to man.

Authors:  C F Higgins
Journal:  Annu Rev Cell Biol       Date:  1992

Review 3.  Rampant caries.

Authors:  Sandra Guzmán-Armstrong
Journal:  J Sch Nurs       Date:  2005-10       Impact factor: 2.835

Review 4.  ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies.

Authors:  Helen S Garmory; Richard W Titball
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 5.  The scientific and public-health imperative for a vaccine against dental caries.

Authors:  Martin A Taubman; David A Nash
Journal:  Nat Rev Immunol       Date:  2006-05-26       Impact factor: 53.106

Review 6.  Role of Streptococcus mutans in human dental decay.

Authors:  W J Loesche
Journal:  Microbiol Rev       Date:  1986-12

7.  The global burden of oral diseases and risks to oral health.

Authors:  Poul Erik Petersen; Denis Bourgeois; Hiroshi Ogawa; Saskia Estupinan-Day; Charlotte Ndiaye
Journal:  Bull World Health Organ       Date:  2005-09-30       Impact factor: 9.408

8.  The ABC transporter protein OppA provides protection against experimental Yersinia pestis infection.

Authors:  Mikio Tanabe; Helen S Atkins; David N Harland; Stephen J Elvin; Anthony J Stagg; Osman Mirza; Richard W Titball; Bernadette Byrne; Katherine A Brown
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 9.  Dental caries vaccine.

Authors:  K M Shivakumar; S K Vidya; G N Chandu
Journal:  Indian J Dent Res       Date:  2009 Jan-Mar

10.  Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors.

Authors:  A Tanghe; P Lefèvre; O Denis; S D'Souza; M Braibant; E Lozes; M Singh; D Montgomery; J Content; K Huygen
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.